Related Experiment Video
Updated: May 7, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Focus on gastrointestinal and liver cancers
William K K Wu1, Joseph J Y Sung
1Institute of Digestive Diseases and State Key Laboratory of Digestive Diseases, Department of Medicine & Therapeutics, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Seminars in Cancer Biology
|October 8, 2013
Summary
Digestive cancers like colorectal, gastric, and liver cancer are evolving threats. Advances in molecular biology and genetics are revealing new insights into their causes and driving the development of novel treatments.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Digestive cancers, including colorectal, gastric, and liver cancer, represent significant and evolving global health challenges.
- Epidemiological patterns of these cancers are undergoing dynamic shifts, necessitating updated research and understanding.
Discussion:
- Recent technological advancements in genotyping and sequencing have significantly improved the understanding of pathogenic mechanisms.
- These technologies, alongside other molecular and cellular biology techniques, are clarifying the interplay between genetic and environmental factors in digestive cancer development.
Key Insights:
- Expanded knowledge of digestive cancer pathogenesis is directly contributing to the discovery of new diagnostic biomarkers.
- This enhanced understanding is also accelerating the development of innovative therapeutic strategies for digestive cancers.
Outlook:
- This special issue reviews critical advancements in basic and translational research for digestive cancers.
- Future research directions will focus on leveraging these insights for improved clinical outcomes and patient care.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...